305 related articles for article (PubMed ID: 15321697)
1. Suppression of paroxysmal atrial tachyarrhythmias--results of the SOPAT trial.
Patten M; Maas R; Bauer P; Lüderitz B; Sonntag F; Dluzniewski M; Hatala R; Opolski G; Müller HW; Meinertz T;
Eur Heart J; 2004 Aug; 25(16):1395-404. PubMed ID: 15321697
[TBL] [Abstract][Full Text] [Related]
2. Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial.
Fetsch T; Bauer P; Engberding R; Koch HP; Lukl J; Meinertz T; Oeff M; Seipel L; Trappe HJ; Treese N; Breithardt G;
Eur Heart J; 2004 Aug; 25(16):1385-94. PubMed ID: 15302102
[TBL] [Abstract][Full Text] [Related]
3. Event-recorder monitoring in the diagnosis of atrial fibrillation in symptomatic patients: subanalysis of the SOPAT trial.
Patten M; Maas R; Karim A; Müller HW; Simonovsky R; Meinertz T
J Cardiovasc Electrophysiol; 2006 Nov; 17(11):1216-20. PubMed ID: 16987384
[TBL] [Abstract][Full Text] [Related]
4. [Conversion rate and prevention of recurrence of paroxysmal and sustained atrial fibrillation or atrial flutter with verapamil/quinidine].
Trappe HJ; Pfitzner P
Med Klin (Munich); 1996 Oct; 91(10):617-25. PubMed ID: 9019638
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine.
Hohnloser SH; van de Loo A; Baedeker F
J Am Coll Cardiol; 1995 Oct; 26(4):852-8. PubMed ID: 7560608
[TBL] [Abstract][Full Text] [Related]
6. [Sotalol and quinidine/verapamil (Cordichin) in chronic atrial fibrillation--conversion and 12-month follow-up--a randomized comparison].
Kalusche D; Stockinger J; Betz P; Roskamm H
Z Kardiol; 1994; 83 Suppl 5():109-16. PubMed ID: 7846939
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of oral propafenone versus quinidine in the treatment of recent onset atrial fibrillation: A randomized, prospective study.
Kosior DA; Kochanowski J; Scisło P; Piatkowski R; Postuła M; Rabczenko D; Opolski G
Cardiol J; 2009; 16(6):521-7. PubMed ID: 19950088
[TBL] [Abstract][Full Text] [Related]
8. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SPPAF), a randomized, placebo-controlled trial.
Auer J; Weber T; Berent R; Puschmann R; Hartl P; Ng CK; Schwarz C; Lehner E; Strasser U; Lassnig E; Lamm G; Eber B;
Am Heart J; 2004 Apr; 147(4):636-43. PubMed ID: 15077078
[TBL] [Abstract][Full Text] [Related]
9. A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. UK Propafenone PSVT Study Group.
Circulation; 1995 Nov; 92(9):2550-7. PubMed ID: 7586356
[TBL] [Abstract][Full Text] [Related]
10. [Combination treatment of atrial arrhythmias with quinidine-verapamil].
Gülker H; Bramann HU; Brisse B; Kuhs H
Med Klin; 1980 Feb; 75(5):196-8. PubMed ID: 6156393
[TBL] [Abstract][Full Text] [Related]
11. [Propafenone and sotalol: long-term efficacy and tolerability in the prevention of paroxysmal atrial fibrillation. A placebo-controlled double-blind study].
Bellandi F; Dabizzi RP; Niccoli L; Cantini F; Palchetti R
G Ital Cardiol; 1996 Apr; 26(4):379-90. PubMed ID: 8707022
[TBL] [Abstract][Full Text] [Related]
12. Prospective randomized study comparing amiodarone vs. amiodarone plus losartan vs. amiodarone plus perindopril for the prevention of atrial fibrillation recurrence in patients with lone paroxysmal atrial fibrillation.
Yin Y; Dalal D; Liu Z; Wu J; Liu D; Lan X; Dai Y; Su L; Ling Z; She Q; Luo K; Woo K; Dong J
Eur Heart J; 2006 Aug; 27(15):1841-6. PubMed ID: 16825288
[TBL] [Abstract][Full Text] [Related]
13. [The effect of sotalol hydrochloride therapy on atrial signal-averaged ECG in patients with paroxysmal atrial fibrillation].
Telichowski A; Banasiak W; Wiech K; Zeborowski J; Pieróg M; Ponikowski P; Kałka D; Lacheta W; Fuglewicz A; Telichowski C
Pol Merkur Lekarski; 1996 Nov; 1(5):303-9. PubMed ID: 9273201
[TBL] [Abstract][Full Text] [Related]
14. Atrial fibrillation: rate control often better than rhythm control.
Prescrire Int; 2004 Apr; 13(70):64-9. PubMed ID: 15148984
[TBL] [Abstract][Full Text] [Related]
15. [Amiodarone and verapamil/quinidine in treatment of patients with chronic atrial fibrillation].
Zehender M; Meinertz T; Just H
Z Kardiol; 1994; 83 Suppl 5():101-8. PubMed ID: 7846938
[TBL] [Abstract][Full Text] [Related]
16. [Medicamentous prevention of symptomatic paroxysmal atrial fibrillation/flutter onset. Goals and design of the SOPAT Study. Executive committee of the investigators representing trial physicians].
Patten M; Koch HP; Sonntag F; Lüderitz B; Meinertz T
Z Kardiol; 1999 Mar; 88(3):185-94. PubMed ID: 10355069
[TBL] [Abstract][Full Text] [Related]
17. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study.
Pappone C; Augello G; Sala S; Gugliotta F; Vicedomini G; Gulletta S; Paglino G; Mazzone P; Sora N; Greiss I; Santagostino A; LiVolsi L; Pappone N; Radinovic A; Manguso F; Santinelli V
J Am Coll Cardiol; 2006 Dec; 48(11):2340-7. PubMed ID: 17161267
[TBL] [Abstract][Full Text] [Related]
18. A randomized comparison of amiodarone and class IC antiarrhythmic drugs to treat atrial fibrillation in patients paced for sinus node disease: the Prevention Investigation and Treatment: A Group for Observation and Research on Atrial arrhythmias (PITAGORA) trial.
Gulizia M; Mangiameli S; Orazi S; Chiarandà G; Piccione G; Di Giovanni N; Colletti A; Pensabene O; Lisi F; Vasquez L; Grammatico A; Boriani G;
Am Heart J; 2008 Jan; 155(1):100-7, 107.e1. PubMed ID: 18082498
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II-antagonist in paroxysmal atrial fibrillation (ANTIPAF) trial.
Goette A; Schön N; Kirchhof P; Breithardt G; Fetsch T; Häusler KG; Klein HU; Steinbeck G; Wegscheider K; Meinertz T
Circ Arrhythm Electrophysiol; 2012 Feb; 5(1):43-51. PubMed ID: 22157519
[TBL] [Abstract][Full Text] [Related]
20. [Medicamentous prevention after electric cardioversion of chronic atrial fibrillation. Goals and design of the PAFAC Study].
Fetsch T; Burschel G; Breithardt G; Engberding R; Koch HP; Lukl J; Trappe HJ; Treese N
Z Kardiol; 1999 Mar; 88(3):195-207. PubMed ID: 10355070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]